BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1711130)

  • 1. [Cytoplasmic staining pattern characteristic for anti Jo-1 antibody in HEp-2 cells].
    Nagano Y; Yoshinoya S; Ohkubo A
    Rinsho Byori; 1991 Mar; 39(3):269-72. PubMed ID: 1711130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular localization of the target structures recognized by the anti-Jo-1 antibody: immunofluorescence studies on cultured human myoblasts.
    Shi MH; Tsui FW; Rubin LA
    J Rheumatol; 1991 Feb; 18(2):252-8. PubMed ID: 2023220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent antibodies in polymyositis using cultured human skin fibroblasts: granular perinuclear cytoplasmic staining pattern by sera from patients with polymyositis and pulmonary fibrosis.
    Saito E; Yoshimoto Y; Oshima H; Yoshida H; Kinoshita M
    J Rheumatol; 1989 Jan; 16(1):47-54. PubMed ID: 2654392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decreased incidence of peripheral nuclear staining pattern by indirect immunofluorescent antibody technique using HEp-2 cells].
    Miyawaki S; Asanuma H
    Ryumachi; 1996 Aug; 36(4):644-50. PubMed ID: 8911082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antinuclear and anticytoplasmic antibodies in 24 cases of dermatomyositis. Value of western blotting].
    Meyer O; Aeschlimann A; Bourgeois P; Belmatoug N; Palazzo E; Haim T; Kahn MF
    Ann Med Interne (Paris); 1989; 140(6):449-52. PubMed ID: 2696398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The principle antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. Study of 42 cases].
    Meyer O; Cremer-Legmann F; Haim T; Ryckewaert A
    Presse Med; 1987 Feb; 16(4):155-8. PubMed ID: 2950445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect immunofluorescence on HEp-2000 substrate is a sensitive method for detecting anti-Ro/SSA antibodies in patients with lupus erythematosus and/or photosensitivity.
    Cozzani E; Drosera M; Siccardi M; Babbini G; Parodi A
    J Rheumatol; 2008 Jul; 35(7):1320-2. PubMed ID: 18528967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of using HEP/2 cells as compared to sections of rat liver in the detection of autoantibodies using indirect immunofluorescence in human pathology].
    Makni S; Jenhani F; Ayed K
    Rev Rhum Mal Osteoartic; 1989 Oct; 56(10):651-5. PubMed ID: 2512629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of human tumor cells (Hep 2) and rat liver for the detection of antinuclear antibodies by indirect immunofluorescence].
    Abuaf N; Prost AC; Rouquette-Gally AM; Bedda N; Fermanian J; Homberg JC
    Ann Biol Clin (Paris); 1984; 42(5):363-9. PubMed ID: 6391298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Jo-1 antibodies.
    Zampieri S; Ghirardello A; Iaccarino L; Tarricone E; Gambari PF; Doria A
    Autoimmunity; 2005 Feb; 38(1):73-8. PubMed ID: 15804708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-nuclear antibodies (ANA) in sera of aged subjects, with special reference to two cases with high titers of anti-centromere antibody (ACA)].
    Moteki S; Yoshida H; Watanabe N; Sato K; Saito M
    Rinsho Byori; 1991 Mar; 39(3):273-7. PubMed ID: 2051602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dense cytoplasmic fluorescence on Hep-2 cells: do not overlook anti-PL].
    Krebs M; Evrard B; Espinouze T; Bonnafoux C; Fabien N; Tridon A
    Pathol Biol (Paris); 2008 Feb; 56(1):15-20. PubMed ID: 18178329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Jo-1 antibody system in myositis: relationships to clinical features and HLA.
    Arnett FC; Hirsch TJ; Bias WB; Nishikai M; Reichlin M
    J Rheumatol; 1981; 8(6):925-30. PubMed ID: 6977032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KB cells for antinuclear antibody determination: comparison with HEp-2 cells and the Crithidia luciliae assay.
    Keil LB; DeBari VA; Needle MA
    Diagn Immunol; 1984; 2(4):213-8. PubMed ID: 6396019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of circulating anticellular antibodies by indirect immunofluorescence on HEp-2 cell substrates: study of the clinical value of rare fluorescence patterns].
    Haberhauer G; Bröll H
    Z Gesamte Inn Med; 1988 Jul; 43(14):377-80. PubMed ID: 3064447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and identification of significant ANAs in previously determined ANA negative samples.
    Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
    Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.